Sunil Healthcare Ltd

NSE: SUNLOC · BSE: 537253 · Pharmaceuticals & Biotechnology · 13 announcements

Share price: ₹72.00
Market cap: ₹73.83 Cr
Revenue (annual): ₹87.72 Cr
Net profit (annual): ₹4.01 Cr
P/E (TTM): 20.7×Sector 47.4×
Promoter holding: 73.53%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 4 Board Meeting Date 2 Annual General Meeting 2 Other Announcement 1 Debt & Borrowing 1 Board Meeting Outcome 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

4 announcements with these filters

13 Aug 2026 18:57 IST BSE

Financial Results

Sunil Healthcare Q1 FY27 Results: Net Profit ₹0.5 Cr, Down 44.4% YoY

Sunil Healthcare Ltd reported revenue from operations of ₹19 Cr (-15.9% YoY) and net profit of ₹0.5 Cr (-44.4% YoY) for Q1 FY27.

Key figure: Net profit ₹0.5 Cr · -44.4% YoY

Open full results → Read the filing ↗

29 May 2026 22:21 IST BSE

Financial Results

Sunil Healthcare Financial Results

Sunil Healthcare reported annual revenue of ₹87.72 Crore for FY 2025-26. The board also appointed M/s. Agrawal S. Lal & Co. as internal auditors.

Value: ₹87.72 Cr

Read the filing ↗

29 May 2026 22:12 IST BSE

Financial Results

Sunil Healthcare Q4 FY26 Results: Net Profit ₹1.5 Cr, Up 275.0% YoY

Sunil Healthcare Ltd reported revenue from operations of ₹19.7 Cr (-7.1% YoY) and net profit of ₹1.5 Cr (+275.0% YoY) for Q4 FY26.

Key figure: Net profit ₹1.5 Cr · +275.0% YoY

Open full results → Read the filing ↗

29 May 2026 22:12 IST BSE

Financial Results

Sunil Healthcare Financial Results

Sunil Healthcare Ltd reported audited financial results for the year ended March 31, 2026. The company also appointed M/s. Agrawal S. Lal & Co. as internal auditors.

Read the filing ↗